Efficacy and Safety of a Monthly Buprenorphine Depot Injection for Opioid Use Disorder: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3228895 ◽

2018 ◽

Author(s):

Barbara R. Haight ◽

Susan M. Learned ◽

Celine M. Laffont ◽

Paul J. Fudala ◽

Yue Zhao ◽

...

Keyword(s):

Controlled Trial ◽

Opioid Use Disorder ◽

Efficacy And Safety ◽

Opioid Use ◽

Double Blind ◽

Double Blind Placebo ◽

Depot Injection

Download Full-text

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet ◽

10.1016/s0140-6736(18)32259-1 ◽

2019 ◽

Vol 393 (10173) ◽

pp. 778-790 ◽

Cited By ~ 54

Author(s):

Barbara R Haight ◽

Susan M Learned ◽

Celine M Laffont ◽

Paul J Fudala ◽

Yue Zhao ◽

...

Keyword(s):

Opioid Use Disorder ◽

Efficacy And Safety ◽

Opioid Use ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Depot Injection

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1088945.542078 ◽

2007 ◽

Author(s):

Jonathan Schapiro

Keyword(s):

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hiv 1

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108987.566149 ◽

2008 ◽

Author(s):

Johann Gudjonsson

Keyword(s):

Monoclonal Antibody ◽

Controlled Trial ◽

Interleukin 12 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958672.793516776 ◽

2016 ◽

Author(s):

Robin Spiller

Keyword(s):

Irritable Bowel Syndrome ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718524881.793498396 ◽

2014 ◽

Author(s):

David Daikh

Keyword(s):

Ankylosing Spondylitis ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial

EP Europace ◽

10.1093/europace/eur416 ◽

2012 ◽

Vol 14 (6) ◽

pp. 804-809 ◽

Cited By ~ 118

Author(s):

A. J. Camm ◽

E. Toft ◽

C. Torp-Pedersen ◽

P. Vijayaraman ◽

S. Juul-Moller ◽

...

Keyword(s):

Atrial Flutter ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Urology ◽

10.1016/j.urology.2021.01.018 ◽

2021 ◽

Author(s):

Kai Zhang ◽

Yuexin Liu ◽

Wenbo Yang ◽

Jiaji Wang ◽

Jianlin Yang ◽

...

Keyword(s):

Pelvic Pain ◽

Chronic Prostatitis ◽

Chronic Pelvic Pain ◽

Controlled Trial ◽

Chronic Pelvic Pain Syndrome ◽

Pain Syndrome ◽

Pelvic Pain Syndrome ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

929g Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomized, double-blind, placebo-controlled trial

Gastroenterology ◽

10.1016/s0016-5085(14)60571-0 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-160 ◽

Cited By ~ 2

Author(s):

Yan Yiannakou ◽

Michel Bouchoucha ◽

Ingolf Schiefke ◽

Hubert Piessevaux ◽

Rafal Filip ◽

...

Keyword(s):

Chronic Constipation ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Results of a global phase 3, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of sebelipase alfa as an enzyme replacement therapy in children and adults with lysosomal acid lipase deficiency

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2014.12.042 ◽

2015 ◽

Vol 114 (2) ◽

pp. S27

Author(s):

Barbara Burton

Keyword(s):

Enzyme Replacement Therapy ◽

Replacement Therapy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Acid Lipase ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Lysosomal Acid ◽

Enzyme Replacement

Download Full-text

PWE-252 Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomised, double-blind, placebo-controlled trial

Gut ◽

10.1136/gutjnl-2015-309861.698 ◽

2015 ◽

Vol 64 (Suppl 1) ◽

pp. A323.2-A324

Author(s):

Y Yiannakou ◽

M Bouchoucha ◽

I Schiefke ◽

H Piessevaux ◽

R Filip ◽

...

Keyword(s):

Chronic Constipation ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text